/SRTA

SRTA Stock - Strata Critical Medical, Inc.

Q: What is the analyst price target for SRTA?

Analyst price target information is not currently available for SRTA.

Q: What is SRTA's market cap?

Market capitalization information is not currently available for SRTA.

Industrials|Airlines, Airports & Air Services|NASDAQ

$5.13-1.54%

$0.08 (-1.54%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+41.3%upside

Target: $7.25

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SRTA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.21

52W High$6.02

52W Low$2.35

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$248.69M	$225.18M	$146.12M	$50.53M	$23.43M
Gross Profit	$58.92M	$42.12M	$22.27M	$10.52M	$2.33M
Gross Margin	23.7%	18.7%	15.2%	20.8%	9.9%
Operating Income	$-33,926,000	$-68,117,000	$-53,529,000	$-24,093,000	$-10,359,000
Net Income	$-27,307,000	$-56,076,000	$-27,260,000	$-40,052,000	$-10,160,000
Net Margin	-11.0%	-24.9%	-18.7%	-79.3%	-43.4%
EPS	$-0.35	$-0.76	$-0.38	$-0.57	$-0.81

Company Overview

Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

100%

Hold / Neutral

Sell / Underperform

Analyst Consensus🟢 Bullish

1 Bullish0 Neutral/Bearish

Price Targets

Average Target

↑ 55.9% Upside

Now

Low

Average

High

Based on 1 analyst

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
December 2nd 2025	Lake Street	Resumed	Buy	$8

Earnings History & Surprises

SRTA

Beat Rate

61%

Last 18 quarters

Avg Surprise

-139.6%

EPS vs Estimate

Beats / Misses

11/5

2 met exactly

Latest EPS

$-0.06

Q4 2025

EPS Surprise History

Q1 24

-76.9%

$-0.23vs$-0.13

Q2 24

+53.8%

$-0.06vs$-0.13

Q3 24

0.0%

$-0.06vs$-0.06

Q4 24

+50.0%

$-0.03vs$-0.06

Q1 25

0.0%

$-0.12vs$-0.12

Q2 25

+63.6%

$-0.04vs$-0.11

Q3 25

-25.0%

$-0.05vs$-0.04

Q4 25

-200.0%

$-0.06vs$-0.02

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 12, 2026	$-0.09	—	—	—
Q4 2025	Nov 10, 2025	$-0.02	$-0.06	-200.0%	✗ MISS
Q3 2025	Aug 5, 2025	$-0.04	$-0.05	-25.0%	✗ MISS
Q2 2025	May 12, 2025	$-0.11	$-0.04	+63.6%	✓ BEAT
Q1 2025	Mar 13, 2025	$-0.12	$-0.12	0.0%	= MET
Q4 2024	Nov 12, 2024	$-0.06	$-0.03	+50.0%	✓ BEAT
Q3 2024	Aug 7, 2024	$-0.06	$-0.06	0.0%	= MET
Q2 2024	May 7, 2024	$-0.13	$-0.06	+53.8%	✓ BEAT
Q1 2024	Mar 12, 2024	$-0.13	$-0.23	-76.9%	✗ MISS
Q4 2023	Nov 8, 2023	$-0.10	$0.00	+103.6%	✓ BEAT
Q3 2023	Aug 9, 2023	$-0.14	$-0.11	+21.4%	✓ BEAT
Q2 2023	May 11, 2023	$-0.21	$-0.14	+33.3%	✓ BEAT
Q1 2023	Mar 15, 2023	$-0.19	$-0.23	-21.1%	✗ MISS
Q4 2022	Nov 10, 2022	$-0.14	$-0.13	+7.1%	✓ BEAT
Q3 2022	Aug 9, 2022	$-0.13	$-0.09	+30.8%	✓ BEAT
Q2 2022	May 10, 2022	$-0.21	$-0.16	+23.8%	✓ BEAT
Q1 2022	Feb 10, 2022	$-0.21	$-0.13	+38.1%	✓ BEAT
Q4 2021	Dec 20, 2021	$-0.14	$-0.13	+7.1%	✓ BEAT
Q3 2021	Aug 16, 2021	$-0.01	$-0.15	-2622.3%	✗ MISS
Q2 2021	May 17, 2021	—	$-0.33	—	—

Frequently Asked Questions about SRTA

What is SRTA's current stock price?

Strata Critical Medical, Inc. (SRTA) is currently trading at $5.13 per share. The stock has moved -1.54% today.

What is the analyst price target for SRTA?

The average analyst price target for SRTA is $7.25, based on 1 analyst.

What sector is Strata Critical Medical, Inc. in?

Strata Critical Medical, Inc. operates in the Industrials sector, specifically within the Airlines, Airports & Air Services industry. The company is traded on the NASDAQ exchange.

What is SRTA's market cap?

Strata Critical Medical, Inc. has a market capitalization of $0.44 billion, making it a small-cap company.

Does SRTA pay dividends?

No, Strata Critical Medical, Inc. does not currently pay a dividend to shareholders.